Characterisation and applications of synthesised cation exchanger guar gum sulphonic acid (GSA) resin for removal and recovery of toxic metal ions from industrial wastewater

The chemically modified guar gum sulphonic acid (GSA) resin was used for removal and pre-concentration of Zn2+, Cd2+, Fe2+, Pb2+ and Cu2+ ions in aqueous solutions and steel industry effluent from Jodhpur, India. This type of ion exchange resin represents a new class of hybrid ion exchangers with higher stability, reproducibility and selectivity for toxic metal ions. The characterisation of the resin was carried out by determining the ion exchange capacity, elemental analysis, FT-IR spectra and thermal analysis (TGA). The distribution coefficients (Kd) of toxic metal ions were determined for differentpH values. The adsorption of different metal ions on GSA resin follows the order: Cu2+ > Fe2+ > Zn2+ > Cd2+ > Pb2+. The adsorbency of different metal ions on the GSA resin was studied for up to 10 cycles

CLINICAL CORRELATION OF AMAVATA WITH ARTHROPATHIES

Objective: The objective of the study was to evaluate the disease Amavata with current understanding of International Classification of Diseases (ICD) 2010.Methods: For the present clinical study, a total of 100 patients were selected. Selection of the patients was done using subjective criteria (mentioned in Ayurvedic samhitas) to diagnose Amavata. Moreover, these patients were classified into three stages according to duration (<6 months, more than 6 months, more than 1 year) of disease. Laboratory investigations were advised such as hematological parameters and collagen profile.Results: A total of 100 cases of Amavata were divided into two groups based on ICD classification 2010. 86 cases of Amavata patients were diagnosed as rheumatoid arthritis including all the three stages. 14 cases of Amavata were diagnosed as systemic lupus erythematosus, reactive arthritis, and ankylosing spondylitis including all the three stages.Conclusion: Amavata is a syndrome may be correlated to arthropathies described under ICD classification 2010

Long-standing unreduced anterior dislocation of the knee - a case report

A case of long standing unreduced anterior dislocation of the knee for 2 months has been reported which was treated first with open reduction and external fixation at 70° flexion of knee followed by gradual extension of knee. Once full extension was achieved, the cylindrical cast was applied for 3 months. The final range of movement of knee at one year follow up was 5-70º along with painless weight bearing. To conclude, this conservative treatment could be one of the valuable option for the patients who can not undergo major surgery because of genreral health problem, or unable to afford for the surgery especially in developing countries, or not willing for arthrodesis.KEY WORDS: Knee joint; Dislocation; Conservative treatmen

Nature and role of root exudates: Efficacy in bioremediation

Root exudate is one of the ways for plant communication to the neighboring plant and adjoining of microorganisms present in the rhizosphere of the root. The chemicals ingredients of the root exudates are specific to a particular plant species and also depend on the nearby biotic and abiotic environment. The chemical ingredient exuded by plant roots include amino acids, sugars, organic acids, vitamins, nucleotides, various other secondary metabolites and many other high molecular weight substances as primarily mucilage and some unidentified substances. Through the exudation of a wide variety of compounds, roots may regulate the soil microbial community in their immediate vicinity, cope with herbivores, encourage beneficial symbioses, change the chemical and physical properties of the soil and inhibit the growth of competing plant species. Root exudates mediate various positive and negative interactions like plant-plant and plant-microbe interactions. The present review has been undertaken to examine the possible role of root exudates on the removal of the polluted matter and nourishing the neighboring microorganisms present in the rhizosphere of the root.Key words: Rhizosphere, root exudates, bioremediation, rhizoremediation

Micro-total envelope system with silicon nanowire separator for safe carcinogenic chemistry

Exploration and expansion of the chemistries involving toxic or carcinogenic reagents are severely limited by the health hazards their presence poses. Here, we present a micro-total envelope system (mu-TES) and an automated total process for the generation of the carcinogenic reagent, its purification and its utilization for a desired synthesis that is totally enveloped from being exposed to the carcinogen. A unique microseparator is developed on the basis of SiNWs structure to replace the usual exposure-prone distillation in separating the generated reagent. Chloromethyl methyl ether chemistry is explored as a carcinogenic model in demonstrating the efficiency of the mu-TES that is fully automated so that feeding the ingredients for the generation is all it takes to produce the desired product. Syntheses taking days can be accomplished safely in minutes with excellent yields, which bodes well for elevating the carcinogenic chemistry to new unexplored dimensions.119Ysciescopu

Molecular investigations on grain filling rate under terminal heat stress in bread wheat (Triticum aestivum L.)

Grain yield under post anthesis high temperature stress is largely influenced by grain filling rate (GFR). To investigate molecular basis of this trait, a set of 111 recombinant inbred lines (RILs) derived from Raj 4014, a heat sensitive genotype and WH 730, heat tolerant cultivar was phenotyped during 2009-2010 and 2010-2011 crop seasons, under field conditions. The difference in GFR (dGFR) between the timely and late sown conditions was used as a phenotypic parameter to find association with molecular markers, as parental lines exhibited significant difference for this trait. The mapping population showed clear-cut segregation pattern for differences in GFR between timely and late sown conditions. About 75% of the progenies showed no difference while 25% showed significant difference in GFR under high temperature stress created by late sown condition. To study the association of this trait with the markers, the parental lines were screened with 300 simple sequence repeat (SSR) microsatellite markers out of which 15% (45) were polymorphic between parental lines. These polymorphic markers were utilized for genotyping a subset, comprising of 43 RILs that had clear contrasting variation for dGFR. Regression analysis revealed significant association of dGFR of RILs with two markers viz., Xbarc04 and Xgwm314 with coefficients of determination (R2) values of 0.10 and 0.06, respectively.Keywords: Grain filling rate (GFR), simple sequence repeat (SSR), heat tolerance, wheatAfrican Journal of Biotechnology Vol. 12(28), pp. 4439-444

The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies.

BACKGROUND: Reducing the severity of respiratory symptoms is a key goal in the treatment of chronic obstructive pulmonary disease (COPD). We evaluated the effect of aclidinium bromide 400 μg twice daily (BID) on respiratory symptoms, assessed using the Evaluating Respiratory Symptoms in COPD (E-RS(™): COPD) scale (formerly EXACT-RS). METHODS: Data were pooled from the aclidinium 400 μg BID and placebo arms of two 24-week, double-blind, randomized Phase III studies evaluating aclidinium monotherapy (ATTAIN) or combination therapy (AUGMENT COPD I) in patients with moderate to severe airflow obstruction. Patients were stratified by Global initiative for chronic Obstructive Lung Disease (GOLD) Groups A-D. Change from baseline in E-RS scores, proportion of responders (patients achieving pre-defined improvements in E-RS scores), and net benefit (patients who improved minus patients who worsened) were analyzed. RESULTS: Of 1210 patients, 1167 had data available for GOLD classification. Mean (standard deviation) age was 63.2 (8.6) years, 60.7 % were male, and mean post-bronchodilator forced expiratory volume in 1 s was 54.4 % predicted. Compared with placebo, aclidinium 400 μg BID significantly improved RS-Total (2.38 units vs 0.79 units, p < 0.001) and domain scores (all p < 0.001) at Week 24, and doubled the likelihood of being an RS-Total score responder (p < 0.05), irrespective of GOLD group. The net benefit for RS-Total (Overall: 56.9 % vs 19.4 %; A + C: 65.7 % vs 6.3 %; B + D: 56.0 % vs 20.8 %, for aclidinium 400 μg BID and placebo respectively; all p < 0.05) and domain scores (all p < 0.05) was significantly greater with aclidinium compared with placebo, in both GOLD Groups A + C and B + D. CONCLUSIONS: Aclidinium 400 μg BID significantly improved respiratory symptoms regardless of the patients' level of symptoms at baseline. Net treatment benefit was similar in patients with low or high levels of symptoms. TRIAL REGISTRATION: ATTAIN (ClinicalTrials.gov identifier: NCT01001494 ) and AUGMENT COPD I (ClinicalTrials.gov identifier: NCT01437397 )

Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective.

Atopic dermatitis (AD) is an inflammatory disorder centered around loss of epidermal barrier function, and T helper 2 (Th2) immune responses. The current understanding of disease heterogeneity and complexity, limits the rational use of existing topical, systemic therapeutic agents, but paves way for development of advanced therapeutic agents. Additionally, advanced nanocarriers that deliver therapeutics to target cells, seem to offer a promising strategy, to overcome intrinsic limitations and challenges of conventional, and traditional drug delivery systems. Ever-evolving understanding of molecular target sites and complex pathophysiology, adverse effects of current therapeutic options, inefficient disease recapitulation by existing animal models are some of the challenges that we face. Also, despite limited success in market translatibility, nanocarriers have demonstrated excellent preclinical results and have been extensively studied for AD. Detailed research on behavior of nanocarriers in different patients and tailored therapy to account for phenotypic variability of the disease are the new research avenues that we look forward to